Skip to main content
Erschienen in: Journal of General Internal Medicine 4/2019

08.01.2019 | Concise Research Reports

Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017

verfasst von: Aishwarya Vijay, BS, Joseph S. Ross, MD, MHS, Nilay D. Shah, PhD, Molly M. Jeffery, PhD, Sanket S. Dhruva, MD, MHS

Erschienen in: Journal of General Internal Medicine | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Excerpt

In 2015, 38% of adults used prescription opioids, with slightly higher rates among older adults.1 Risks of opioids have been well-described and are greater among older adults and when used concurrently with three commonly prescribed “opioid potentiator” drug classes: benzodiazepines, non-benzodiazepine sedative hypnotics, and gabapentinoids.2, 3 These drugs also have risks when used on their own; in particular, there has been an increasing risk of death associated with benzodiazepine use.4
Literatur
1.
Zurück zum Zitat Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Ann. Intern. Med. 2017;167(5):293–301.CrossRefPubMed Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Ann. Intern. Med. 2017;167(5):293–301.CrossRefPubMed
3.
Zurück zum Zitat Gomes T, Greaves S, van den Brink W, et al. Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. Ann. Intern. Med. 2018. Gomes T, Greaves S, van den Brink W, et al. Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. Ann. Intern. Med. 2018.
5.
Zurück zum Zitat Samuels EA, Ross JS, Dhruva SS. Medicare formulary coverage restrictions for prescription opioids, 2006 to 2015. Ann. Intern. Med. 2017;167(12):895–896.CrossRefPubMed Samuels EA, Ross JS, Dhruva SS. Medicare formulary coverage restrictions for prescription opioids, 2006 to 2015. Ann. Intern. Med. 2017;167(12):895–896.CrossRefPubMed
Metadaten
Titel
Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017
verfasst von
Aishwarya Vijay, BS
Joseph S. Ross, MD, MHS
Nilay D. Shah, PhD
Molly M. Jeffery, PhD
Sanket S. Dhruva, MD, MHS
Publikationsdatum
08.01.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 4/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4752-8

Weitere Artikel der Ausgabe 4/2019

Journal of General Internal Medicine 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.